Patents by Inventor Jawida LEZAAR

Jawida LEZAAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11573240
    Abstract: Disclosed are methods for diagnosing CAT1-related diseases, wherein the methods include detecting CAT1 in a cell by a BLV.RBD ligand, or a variant or a fragment thereof. Also disclosed is a BLV.RBD ligand, or a variant or a fragment thereof for use in the treatment of CAT1-related diseases and/or BLV infections.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: February 7, 2023
    Assignees: METAFORA BIOSYSTEMS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE MONTPELLIER, UNIVERSITÉ PARIS CITÉ
    Inventors: Svilena Ivanova, Donatella Giovannini, Julien Bellis, Jawida Lezaar, Vincent Petit, Jean-Luc Battini, Marc Sitbon, Valérie Courgnaud
  • Publication number: 20220003782
    Abstract: Methods for detecting and/or measuring the level of sodium-dependent multivitamin transporter (SMVT) in a biological sample. The methods include the steps of: (a) contacting the biological sample with a PERV-B.RBD ligand, a variant and/or a fragment thereof; and, detecting and/or measuring the binding of the PERV-B.RBD ligand, variant and/or fragment thereof to SMVT.
    Type: Application
    Filed: October 7, 2019
    Publication date: January 6, 2022
    Applicants: METAFORA BIOSYSTEMS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE MONTPELLIER, UNIVERSITÉ DE PARIS
    Inventors: Marc SITBON, Vincent PETIT, Svilena IVANOVA, Jean-Luc BATTINI, Valérie COURGNAUD, Donatella GIOVANNINI, Jawida LEZAAR
  • Publication number: 20180335435
    Abstract: Disclosed are methods for diagnosing CAT1-related diseases, wherein the methods include detecting CAT1 in a cell by a BLV.RBD ligand, or a variant or a fragment thereof. Also disclosed is a BLV.RBD ligand, or a variant or a fragment thereof for use in the treatment of CAT1-related diseases and/or BLV infections.
    Type: Application
    Filed: November 18, 2016
    Publication date: November 22, 2018
    Inventors: Svilena IVANOVA, Donatella GIOVANNINI, Julien BELLIS, Jawida LEZAAR, Vincent PETIT, Jean-Luc BATTINI, Marc SITBON, Valérie COURGNAUD